Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Fentanyl
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Ethypharm
Deal Size : Undisclosed
Deal Type : Partnership
Ethypharm and RSSL Fast-Track Medicine for COVID-19 Patients
Details : The collaboration is intended to accelerate the manufacture and batch release of fentanyl injection; one of the critical medicines needed for the treatment of COVID-19 patients.
Product Name : Undisclosed
Product Type : Controlled Substance
Upfront Cash : Undisclosed
June 04, 2020
Lead Product(s) : Fentanyl
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Ethypharm
Deal Size : Undisclosed
Deal Type : Partnership
Reset All
